סלסנטרי 300 מ"ג - Celsentri 300 mg
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | J05AX Other antivirals | |||||||||||||||||
| ×ר××× ×¤×¢×× (ATC5) | Â
| |||||||||||||||||
| צ×רת ××ª× | פ××× - PER OS | |||||||||||||||||
| צ×רת ××× ×× | ×××××ת ×צ×פ×ת פ×××, FILM COATED TABLETS ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | |||||||||||||||||
| ×ת×××× | Celsentri is a CCR5 co-receptor antagonist indicated for combination antiretroviral treatment of adults infected with only CCR5-tropic HIV-1.⢠In treatment-naïve subjects, more subjects treated with Celsentri experienced virologic failure and developed lamivudine resistance compared to efavirenz.⢠Tropism testing with a highly sensitive tropism assay is required for the appropriate use of Celsentri. | |||||||||||||||||
| ||||||||||||||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
 Â
| |||||||||||||||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| ס××¡× ××¨× 300 ×"× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | PFIZER MANUFACTURING DEUTSCHLAND GMBH, GERMANY |
| ×©× ××¢× ×ר×ש×× | GLAXO SMITH KLINE (ISRAEL) LTD |
| ר×ש××× | ת×ר×× ××ש×: 08/2007. ר×ש××× ×ת×ר××: 10/2013 |
| ת×ר×× ×¢×××× ××ר×× | 14/05/19 |
השינוי האחרון נעשה בֹ־16 במרץ 2014 ב־21:02